Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2022-08-15
Target enrollment:
Participant gender:
Summary
To evaluate the bioequivalence of a single oral dose of HRX0701 tablets and the reference
formulations retagliptin phosphate tablets and metformin hydrochloride tablets in healthy
subjects in the postprandial state; To evaluate the pharmacokinetic effects of a high-fat
diet on retagliptin and metformin after a single oral administration of HRX0701 tablets in
healthy subjects.